Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT07105319
What this trial is testing

Ropeginterferon for Treatment Free Remission

Who this might be right for
CML (Chronic Myelogenous Leukemia)
Dong-Wook Kim 65
Not applicableLooking for participantsNCT04641936
What this trial is testing

Urine Omics Predicting IO Therapy Responses in mUC Patients

Who this might be right for
Metastatic Urothelial Carcinoma
National Taiwan University Hospital 600
Not applicableActive Not RecruitingNCT06522971
What this trial is testing

Effects of Physical Exercise on Response to Treatement in Breast Cancer

Who this might be right for
Breast Cancer
Latvian Biomedical Research and Study Centre 55
Not applicableStudy completedNCT00867711
What this trial is testing

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
MALIGNANT PLEURAL MESOTHELIOMA
Istituto Clinico Humanitas 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT05231629
What this trial is testing

Sequential Therapy in Multiple Myeloma Guided by MRD Assessments

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 300
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Post-approval studies (Phase 4)Not Yet RecruitingNCT07093931
What this trial is testing

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 468
Large-scale testing (Phase 3)Study completedNCT01462357
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,079
Testing effectiveness (Phase 2)Ended earlyNCT01405846
What this trial is testing

Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib

Who this might be right for
Lung CancerHead and Neck Cancer
Papworth Hospital NHS Foundation Trust 32
Not applicableActive Not RecruitingNCT04472910
What this trial is testing

GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma

Who this might be right for
Resectable Pancreatic Cancer
University Health Network, Toronto 84
Testing effectiveness (Phase 2)Study completedNCT00799513
What this trial is testing

Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
IRCCS San Raffaele 48
Not applicableTemporarily pausedNCT05206942
What this trial is testing

Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy

Who this might be right for
Solid Tumor
Stanford University 30
Not applicableActive Not RecruitingNCT01276574
What this trial is testing

Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Turku University Hospital 150
Not applicableUnknownNCT03652142
What this trial is testing

Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNSCCDNA DamageDNA Double Strand Break
Attikon Hospital 50
Testing effectiveness (Phase 2)WithdrawnNCT05371860
What this trial is testing

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Armando Giuliano
Testing effectiveness (Phase 2)WithdrawnNCT05483023
What this trial is testing

18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

Who this might be right for
Complex Atypical HyperplasiaEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Not applicableNot Yet RecruitingNCT06330896
What this trial is testing

Disease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation Sequencing

Who this might be right for
Plasma Cell Disorder
Siriraj Hospital 498
Testing effectiveness (Phase 2)Study completedNCT02830880
What this trial is testing

FACBC Prostate Therapy Response

Who this might be right for
Prostate Cancer
Emory University 7
Not applicableStudy completedNCT00899418
What this trial is testing

Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 500
Not applicableNot Yet RecruitingNCT07529496
What this trial is testing

The Effect of Psychosocial Support on Improving Breast Cancer Patients Response to Medical Treatment

Who this might be right for
Breast Cancer - Female
Al-Quds University 160
Next Page